| Jamie Dawn Bannister, APRN-CNP | |
|
409 Alfred St Ste 4-5, Biddeford, ME 04005-3756 | |
| (207) 346-5807 | |
| Not Available |
| Full Name | Jamie Dawn Bannister |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 409 Alfred St Ste 4-5, Biddeford, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093316796 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WP0808X | Registered Nurse - Psychiatric/mental Health | RN61568 (Maine) | Secondary |
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | CNP221277 (Maine) | Primary |
| Entity Name | Savida Health, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588226328 PECOS PAC ID: 4082809967 Enrollment ID: O20190807001538 |
News Archive
A new study shows that a combination of epigenetic therapy and molecular targeted therapy has promising results at combating advanced lung cancer according to research presented at the 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology. This symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (ISLAC) and The University of Chicago.
Cortex Pharmaceuticals, Inc. reported a net loss applicable to common stock of approximately $528,000, or $0.01 per share, for the quarter ended September 30, 2010, compared with a net loss applicable to common stock of approximately $3,243,000 or $0.06 per share, for the prior year quarter.
Stimulant medications, such as Ritalin and Adderall, are the accepted treatment to stem hyperactivity in children with attention deficit-hyperactive disorder (ADHD) and improve their behavior.
Years of research show black patients getting less treatment in the American health care system than their white counterparts, but a new study suggests that a quick dose of empathy helps close racial gaps in pain treatment.
African-American women with breast cancer were more likely to have larger, later-stage tumors that were more difficult to treat and also had lower survival rates than Hispanic and Caucasian women who received the same treatment in two independent series of clinical trials examined by researchers from The University of Texas M. D. Anderson Cancer Center.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jamie Dawn Bannister, APRN-CNP 317 Turner St, Auburn, ME 04210-6038 Ph: (207) 577-9426 | Jamie Dawn Bannister, APRN-CNP 409 Alfred St Ste 4-5, Biddeford, ME 04005-3756 Ph: (207) 346-5807 |
News Archive
A new study shows that a combination of epigenetic therapy and molecular targeted therapy has promising results at combating advanced lung cancer according to research presented at the 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology. This symposium is co-sponsored by the American Society for Radiation Oncology (ASTRO), the American Society of Clinical Oncology (ASCO), the International Association for the Study of Lung Cancer (ISLAC) and The University of Chicago.
Cortex Pharmaceuticals, Inc. reported a net loss applicable to common stock of approximately $528,000, or $0.01 per share, for the quarter ended September 30, 2010, compared with a net loss applicable to common stock of approximately $3,243,000 or $0.06 per share, for the prior year quarter.
Stimulant medications, such as Ritalin and Adderall, are the accepted treatment to stem hyperactivity in children with attention deficit-hyperactive disorder (ADHD) and improve their behavior.
Years of research show black patients getting less treatment in the American health care system than their white counterparts, but a new study suggests that a quick dose of empathy helps close racial gaps in pain treatment.
African-American women with breast cancer were more likely to have larger, later-stage tumors that were more difficult to treat and also had lower survival rates than Hispanic and Caucasian women who received the same treatment in two independent series of clinical trials examined by researchers from The University of Texas M. D. Anderson Cancer Center.
› Verified 6 days ago
Halee Storey, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 22 W Cole Rd Ste 101, Biddeford, ME 04005 Phone: 207-780-6565 | |
Ms. Jamie Osgood Wendt, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 9 Healthcare Dr, Biddeford, ME 04005 Phone: 207-282-4270 | |
Kali Ann Waters, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 9 Healthcare Dr, Biddeford, ME 04005 Phone: 207-283-1427 | |
Heather J Lemire, WHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 9 Healthcare Drive, Suite 101, Biddeford, ME 04005 Phone: 207-282-4270 Fax: 207-272-7350 | |
Lindsey Lucas, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 46 Barra Rd, Biddeford, ME 04005 Phone: 207-282-3349 | |
Lorraine Ware Rioux, ANP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Biddeford, ME 04005 Phone: 207-283-7454 Fax: 207-283-7476 | |
Christopher John Krupa-schayer, APRN, AGACNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 9 Healthcare Dr Ste 105, Biddeford, ME 04005 Phone: 207-282-3666 |